GROTTELLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 819
EU - Europa 526
AS - Asia 358
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 1.709
Nazione #
US - Stati Uniti d'America 813
IE - Irlanda 178
SG - Singapore 145
IT - Italia 107
UA - Ucraina 87
HK - Hong Kong 67
CN - Cina 61
VN - Vietnam 59
FI - Finlandia 32
DE - Germania 25
RO - Romania 22
RU - Federazione Russa 17
KR - Corea 14
BE - Belgio 12
GB - Regno Unito 9
FR - Francia 8
TR - Turchia 6
CZ - Repubblica Ceca 5
NL - Olanda 5
SE - Svezia 5
AT - Austria 4
EU - Europa 4
MX - Messico 4
CH - Svizzera 3
CA - Canada 2
CL - Cile 2
JP - Giappone 2
LB - Libano 2
LT - Lituania 2
UZ - Uzbekistan 2
BG - Bulgaria 1
GR - Grecia 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 1.709
Città #
Chandler 196
Dublin 178
Singapore 120
Hong Kong 66
San Mateo 64
Dong Ket 59
Perugia 53
Boardman 50
Jacksonville 47
Santa Clara 42
Ann Arbor 31
Medford 31
Princeton 31
Altamura 26
Wilmington 24
Lawrence 23
Bucharest 20
Andover 18
Falls Church 18
Beijing 14
Seoul 13
Brussels 12
Fremont 11
Helsinki 10
Ashburn 7
Des Moines 6
Izmir 6
Norwalk 6
Redmond 6
Chicago 5
Dallas 5
Redwood City 5
Saint Petersburg 5
San Paolo di Civitate 5
Brno 4
Dearborn 4
Montefalco 4
Frankfurt Am Main 3
Harbin 3
Los Angeles 3
Woodbridge 3
Amsterdam 2
Assisi 2
Celaya 2
Den Haag 2
Gualtieri 2
Munich 2
New York 2
Salvatierra 2
San Diego 2
Shanghai 2
Urbino 2
Vienna 2
Ansan-si 1
Auxvasse 1
Bratislava 1
Castiglione Del Lago 1
Espoo 1
Fairfax 1
Fairfield 1
Frankfurt am Main 1
Groningen 1
Kiev 1
La Canada Flintridge 1
Langfang 1
Moscow 1
Nagold 1
Olomouc 1
Ottawa 1
Padova 1
Philadelphia 1
Rome 1
Saint Louis 1
Timisoara 1
Toronto 1
Washington 1
Wuxi 1
Xingtai 1
Zevio 1
Totale 1.287
Nome #
ALPHA-TOCOPHEROL SUCCINATE INHIBITS NF-KAPPA-B NUCLEAR TRANSLOCATION VIA NRF2 ACTIVATION THUS INDUCING A DETOXIFICATION RESPONSE AGAINST PRO-OXIDANT REDOX-CYCLING COMPOUNDS 93
Acetamidine-based iNOS inhibitors as molecular tools to counteract inflammation in BV2 microglial cells 74
Denervation does not Induce Muscle Atrophy Through Oxidative Stress 72
Adenosine A1 receptors contribute to mitochondrial vulnerability to pro-oxidant stressors 71
Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells 70
Potential influence of cyclo(His-pro) on proteostasis: Impact on neurodegenerative diseases 69
Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity 68
Furanodien-6-one from Commiphora erythraea inhibits the NF-κB signalling and attenuates LPS-induced neuroinflammation 66
A(1) and A(3) adenosine receptors alter glutathione status in an organ-specific manner and influence the changes after inhibition of gamma-glutamylcysteine ligase. 62
Cyclo(His-Pro) exerts anti-inflammatory effects by modulating NF-κB and Nrf2 signalling. 62
Peroxynitrite Activates the NLRP3 Inflammasome Cascade in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis 62
Focus on cyclo(His-Pro): history and perspectives as antioxidant peptide. 61
2-Cl-adenosine: an antimetabolite in human prostate cancer PC3 cells. 60
Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up regulation of antioxidant defence. 60
Cyclo (His-Pro) Protects SOD1G93A Microglial Cells from Paraquat Induced Toxicity 59
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 54
Cyclo(His-Pro) promotes cytoprotection by activating Nrf2-mediated up-regulation of antioxidant defence 52
α-Tocopheryl succinate pre-treatment attenuates quinone toxicity in prostate cancer PC3 cells. 50
MITOCHONDRIAL EXPRESSION OF A1 ADENOSINE RECEPTOR EXACERBATES PRO-OXIDANT INJURY 49
Molecular events underlying antioxidant properties of cyclo(His-Pro) in PC12 cells 48
ROS-independent Nrf2 activation in prostate cancer 46
Cyclo(His-Pro) alleviates LPS-induced neuroinflammation 45
Up-regulation of antioxidant defence by cyclo(His-Pro) through Nrf2 activation 43
The role of cyclo(His-Pro) in neurodegeneration 42
Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach 42
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 40
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 33
Molecular and Cellular Studies Reveal Folding Defects of Human Ornithine Aminotransferase Variants Associated With Gyrate Atrophy of the Choroid and Retina 32
Dimerization drives proper folding of human alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 30
Phosphoproteomic analysis of the effect of cyclo-(His-Pro)dipeptide on PC12 cells 29
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 29
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase 28
CRISPR/Cas9-mediated knock-out of AGXT1 in HepG2 cells as a new in vitro model of Primary Hyperoxaluria Type 1 22
Impact of Enniatin and Deoxynivalenol Co-Occurrence on Plant, Microbial, Insect, Animal and Human Systems: Current Knowledge and Future Perspectives 22
Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase 21
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 20
Erratum: Cyclo(His-Pro) up-regulates heme oxygenase 1 via activation of Nrf2-ARE signaling (Journal of Neurochemistry (2009) 111 (956-966)) 15
Commensal fungi and oxalate degradation: is there a link? 14
Molecular Dynamics-Ensemble Docking and Biophysical Studies for Structure-Based Identification of Non-Amino Acidic Ligands of DDAH-1 12
Totale 1.827
Categoria #
all - tutte 8.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 0 0 14 1 19 17 5 4
2020/2021231 3 17 2 13 77 9 12 2 19 1 15 61
2021/2022296 10 39 6 3 14 8 9 83 19 28 33 44
2022/2023581 32 101 9 45 55 58 0 25 220 5 22 9
2023/2024250 22 23 12 3 1 1 44 10 24 7 48 55
2024/2025243 15 49 26 28 80 44 1 0 0 0 0 0
Totale 1.827